Company Filing History:
Years Active: 2016
Title: **Inventor Javier Marin Prida: Pioneering Neuroprotective Innovations**
Introduction
Javier Marin Prida is an accomplished inventor based in La Habana, Cuba. He is recognized for his significant contributions to the field of neuroprotection and neuroregeneration through his innovative inventions. With a focus on treating neurodegenerative and ischemic brain diseases, Marin Prida has made strides in developing therapeutic compounds that hold promise for enhancing human health.
Latest Patents
Javier Marin Prida holds one notable patent titled “Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases.” This invention encompasses peptides that include phycocyanobilin (PCB) and outlines their medical applications due to their identified neuroprotector and neuroregenerative effects. The patent highlights not only the standalone use of these peptides and PCB but also their potential combined effects with other proteins or peptides, making them valuable for treating central nervous system diseases.
Career Highlights
Marin Prida's career is linked with the prestigious Centro de Ingeniería Genética y Biotecnología, where he has been instrumental in advancing biotechnological research. His work has contributed significantly to understanding and developing new treatments for complex neurodegenerative conditions. His commitment to research and innovation demonstrates his dedication to improving healthcare outcomes.
Collaborations
Throughout his career, Marin Prida has collaborated with talented professionals such as Giselle Penton Rol and Alexey Llopiz Arzuaga. Their combined expertise and teamwork have facilitated the exploration of innovative approaches to combat neurological disorders, showcasing the power of collaboration in scientific research.
Conclusion
Javier Marin Prida stands out as a pioneering inventor in the realm of neuroprotective therapies. His dedication to developing effective pharmaceutical compounds for the treatment of neurodegenerative diseases has the potential to change lives. As he continues his work at the Centro de Ingeniería Genética y Biotecnología, the innovations stemming from his research are likely to contribute to significant advancements in neurological health.